论文部分内容阅读
目的：探讨静脉滴注缩宫素辅以宫体注射欣母沛在预防和治疗剖宫产术后出血的临床疗效。方法选择有剖宫产指征、具产后出血潜在因素的高危产妇160例按入：先后顺序，被随机分为观察和对照两组(n=80)。胎儿娩出后，在静脉滴注缩宫素的基础上，观察组辅以宫体注射欣母沛治疗，而对照组辅以宫体注射缩宫素治疗。比较组间产后出血的发生率以及术后2、24h的出血量。结果观察组产后出血发生率低于对照组；观察组产后2、24h的出血量均少于对照组，组间比较差异有统计学意义(<0.05)。结论静脉滴注缩宫素辅以宫体注射欣母沛用于防治产后出血，具有快速、安全的特点，值得推广。“,”Objective To explore the clinical ef icacy of Intravenous infusion of oxytocin combined with uterine body injected hemabate in the prevention and treatment of hemor hage after cesarean section.Methods According to the order of admission, 160 cases of high-risk mothers with indications for cesarean section, were randomly divided into observation and control group two (n=80). After delivery of fetus, in intravenous infusion of oxytocin on the contraction of the basis, the observation group with uterine body injected hemabate treatment, while the control group with injection of oxytocin treatment of uterine body. The incidence of postpartum hemorrhage were compared between and the amount of bleeding in the postoperative 2, 24 h.Results The observation group than in the control group the incidence of postpartum hemor hage, postpartum hemor hage; observation group of 2 volume of 24 h were less than that in the control group, there were statistical y significant dif erences between groups ( < 0.05).Conclusion Intravenous infusion of oxytocin combined with uterine body injected hemabate for prevention of postpartum hemor hage, with fast, safe, worthy of promotion.